MDT

96.46

-0.47%↓

A

146.44

-1.03%↓

VEEV

228.35

-1.98%↓

HQY

84.03

-0.27%↓

PHR.US

16.54

-3.44%↓

MDT

96.46

-0.47%↓

A

146.44

-1.03%↓

VEEV

228.35

-1.98%↓

HQY

84.03

-0.27%↓

PHR.US

16.54

-3.44%↓

MDT

96.46

-0.47%↓

A

146.44

-1.03%↓

VEEV

228.35

-1.98%↓

HQY

84.03

-0.27%↓

PHR.US

16.54

-3.44%↓

MDT

96.46

-0.47%↓

A

146.44

-1.03%↓

VEEV

228.35

-1.98%↓

HQY

84.03

-0.27%↓

PHR.US

16.54

-3.44%↓

MDT

96.46

-0.47%↓

A

146.44

-1.03%↓

VEEV

228.35

-1.98%↓

HQY

84.03

-0.27%↓

PHR.US

16.54

-3.44%↓

Search

Retractable Technologies Inc

Closed

SectorHealthcare

0.73 -2.67

Overview

Share price change

24h

Current

Min

0.73

Max

0.75

Key metrics

By Trading Economics

Income

-10M

-10M

Sales

-360K

10M

EPS

0.01

Profit margin

-101.303

Employees

221

EBITDA

450K

2.3M

Dividends

By Dow Jones

Next Earnings

26 Mar 2026

Market Stats

By TradingEconomics

Market Cap

-225K

24M

Previous open

3.4

Previous close

0.73

News Sentiment

By Acuity

100%

0%

355 / 370 Healthcare

Retractable Technologies Inc Chart

Past performance is not a reliable indicator of future results.

Related News

12 Jan 2026, 23:54 UTC

Market Talk

CBA Could Underperform Again in 2026 -- Market Talk

12 Jan 2026, 23:48 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

12 Jan 2026, 23:48 UTC

Market Talk

Nikkei May Rise on Weaker Yen -- Market Talk

12 Jan 2026, 23:43 UTC

Market Talk

Gold Edges Lower on Likely Technical Correction -- Market Talk

12 Jan 2026, 23:18 UTC

Acquisitions, Mergers, Takeovers

Paramount Sues Warner Bros., Plans Proxy Fight. The Ellisons Aren't Giving Up. -- Barrons.com

12 Jan 2026, 21:56 UTC

Market Talk

Light & Wonder Gets Positive Outcome From Lawsuit -- Market Talk

12 Jan 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

12 Jan 2026, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

12 Jan 2026, 21:50 UTC

Market Talk
Earnings

Auto & Transport Roundup: Market Talk

12 Jan 2026, 21:18 UTC

Market Talk

Global Equities Roundup: Market Talk

12 Jan 2026, 21:18 UTC

Market Talk

Pfizer CEO Sees Large Cash Market for Obesity Drugs -- Market Talk

12 Jan 2026, 20:54 UTC

Earnings

Gap, Fortinet, and More Stocks That Usually Outperform After Earnings -- Barrons.com

12 Jan 2026, 20:48 UTC

Market Talk

Oil Futures Settle Higher in Choppy Trade -- Market Talk

12 Jan 2026, 20:33 UTC

Market Talk

U.S. Natural Gas Jumps on Colder Weather Outlook -- Market Talk

12 Jan 2026, 20:18 UTC

Acquisitions, Mergers, Takeovers

Credit Agricole Sees Banco BPM Stake Helping 2025 Net by EUR200M >ACA.FR

12 Jan 2026, 20:18 UTC

Acquisitions, Mergers, Takeovers

Credit Agricole: European Central Bank Approves Crossing of 20% Threshold in Share Capital of Banco BPM

12 Jan 2026, 19:39 UTC

Market Talk

J&J CEO: Trump Pact Allows Company to Focus on Core Operations -- Market Talk

12 Jan 2026, 19:36 UTC

Market Talk

Gold and Silver Set New Records on Fed Probe -- Market Talk

12 Jan 2026, 19:36 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

12 Jan 2026, 19:33 UTC

Market Talk

Venezuela's 'Proven' Oil Reserves Raises Questions -- Market Talk

12 Jan 2026, 19:24 UTC

Acquisitions, Mergers, Takeovers

Dynavax: 'Party A' CEO Sent a Non-Binding $15/Shr Proposal on Dec. 23

12 Jan 2026, 19:22 UTC

Acquisitions, Mergers, Takeovers

Dynavax Files Tender Offer Recommendation Statement Related to Sanofi Deal, Mentions Talks With 'Party A'

12 Jan 2026, 18:21 UTC

Acquisitions, Mergers, Takeovers

Paramount Plans Proxy Fight to Push Hostile Warner Bid -- 2nd Update

12 Jan 2026, 18:20 UTC

Acquisitions, Mergers, Takeovers

This French Biotech Stock Surged 1,700% in 2025. Eli Lilly Is Taking an Interest. -- Barrons.com

12 Jan 2026, 18:19 UTC

Market Talk

Modest Canadian Economic Impact Seen from Venezuela Changes -- Market Talk

12 Jan 2026, 18:16 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Comcast Could Unlock Value With a Spinoff of NBCUniversal Assets, Analysts Say -- Market Talk

12 Jan 2026, 18:09 UTC

Market Talk

Global Equities Roundup: Market Talk

12 Jan 2026, 18:09 UTC

Market Talk

Baidu's Outlook Bodes Well For Shares -- Market Talk

12 Jan 2026, 18:01 UTC

Acquisitions, Mergers, Takeovers

QXO Is Raising Another $1.8 Billion for Its M&A War Chest -- Barrons.com

12 Jan 2026, 18:00 UTC

Market Talk

Canada's 'Breakeven' Employment Recalibrating -- Market Talk

Peer Comparison

Price change

Retractable Technologies Inc Forecast

Rating Consensus

By TipRanks

0 ratings

0

Buy

0

Hold

0

Sell

Sentiment

By Acuity

355 / 370 Healthcare

News Sentiment

Very Strong Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Retractable Technologies Inc

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.
help-icon Live chat